Obesity Clinical Trial
Official title:
Low-dose CT Angiography in the Detection of Acute Pulmonary Embolism: Validation in an Obese Population
Pulmonary embolism is a common pathology in the general population, whose suspicion is based
on the clinical and dosage of D-dimers in particular.
The key examination for the diagnosis of pulmonary embolism is chest CT angiography (negative
predictive value of 98%).
The evolution of machines in recent years allows a reduction of possible kilovoltage up to 80
kV, different computer algorithms (iterative reconstructions) to reconstruct the images and
thus reduce the irradiation dose with equal image quality (Evaluation of dose CT and adaptive
statistical reconstruction with the same group of patients, Qi et al, 2012; Impact of
iterative reconstruction on the diagnosis of acute pulmonary embolism (PE) on reduced-dose
chest CT angiograms, Pontana et al , 2015) in patient populations with a weight of less than
100 kilos.
However, obesity is a risk factor for pulmonary embolism and the obese population is
increasing, thus requiring optimal management regarding irradiation.
Few studies have evaluated the quality of low dose CT angiography in obese patients. One
study showed the possibility of performing low-dose thoracic CT angiography (100 kV) in
patients up to 125 kg, without loss of subjective quality (but with an impact on objective
quality), without the use of current iterative reconstruction techniques (Diagnostic
confidence and image quality of CT pulmonary angiography at 100 kVp in overweight and obese
patients, Megyeri et al, 2015).
The study seek to prove that in the obese patient, with a low dose examination (voltage of
the tube at 100 kV) and the current iterative reconstructions, the thoracic angioscanner is
not less efficient than in the non obese patient, that the qualities objective and subjective
analyzes are maintained.
The main purpose is to evaluate and compare thoracic CT angiography with weight and BMI, with
identical CT parameters (same voltage, computer reconstruction techniques and same contrast
injection protocol), by evaluating the objective and subjective diagnostic quality of the
opacification of the pulmonary arteries.
Status | Recruiting |
Enrollment | 130 |
Est. completion date | September 2019 |
Est. primary completion date | September 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria : - Patient > 18 - Suspicion of pulmonary embolism - Reparted in 2 groups : - < 30 kg/m2 - > 30 kg/m2 Exclusion criteria : - Allergy to iodine contrast media - Renal impairment with renal creatinine clearance < 30 mL/min - Pregnancy - Refusal to participate in the study |
Country | Name | City | State |
---|---|---|---|
France | CHU de Clermont-Ferrand | Clermont-Ferrand | Auvergne |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Megyeri B, Christe A, Schindera ST, Horkay E, Sikula J, Cullmann JL, Kollar J, Heverhagen JT, Szucs-Farkas Z. Diagnostic confidence and image quality of CT pulmonary angiography at 100 kVp in overweight and obese patients. Clin Radiol. 2015 Jan;70(1):54-61. doi: 10.1016/j.crad.2014.09.014. Epub 2014 Oct 24. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Unit of hounsfield (UH) measurement in region of interest (ROI) | Unit of hounsfield (UH) measurement in region of interest (ROI) in the pulmonary artery, right and left branches, lobar branches, one segmental and subsegmental branch for each lobe, signal / noise ratio and contrast / noise for each ROI | Day 0 | |
Secondary | Scale of confidence (Likert) | Scale of confidence (Likert) on the subjective quality for each reader (2 readers) in 5 points : Total confidence, Good confidence, Neither good or bad confidence, Bad confidence, No confidence at all. Higher values represent a worse outcome. | Day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |